MedPath

CorVent Medical's Respond Ventilator Receives FDA Clearance

• CorVent Medical secured FDA 510(k) clearance for its Respond critical care ventilator, designed for simple, safe, and cost-effective ventilation. • The Respond ventilator combines traditional mechanical ventilation with durable components, eliminating service contracts and using non-proprietary accessories. • Engineered for pediatric to adult patients, Respond features standard breathing modes, invasive/non-invasive ventilation, and a patient-prioritized alarm system. • This marks the first U.S.-manufactured ventilator to receive FDA clearance in over 20 years, revitalizing U.S. manufacturing in the medical device sector.

CorVent Medical has announced that its Respond critical care ventilator system has received FDA 510(k) clearance. The Respond ventilator is designed to provide a cost-effective and reliable option for delivering ventilation in various healthcare settings. The clearance marks a significant step for U.S. manufacturing in the medical device sector, being the first ventilator manufactured in the U.S. to receive FDA clearance in over two decades.
The Respond ventilator combines traditional mechanical ventilation elements with durable, long-lasting components. This design aims to reduce the total cost of ownership by eliminating the need for service and maintenance contracts and utilizing non-proprietary circuits and accessories. The ventilator operates with low-pressure oxygen, further contributing to its long-term affordability.

Key Features and Benefits

According to CorVent, the Respond ventilator is engineered to meet the needs of a broad range of patients, from pediatric to adult. It includes all standard breathing modes and offers both invasive and non-invasive ventilation capabilities. Additional features include a patient-prioritized alarm system, hot-swappable batteries, and communication capabilities for EMR integration.
Dr. Patrick Troy, chief medical officer at CorVent Medical, emphasized the ventilator's value proposition: “Simple and highly reliable, the Respond ventilator is a front-line ventilator in a value-focused and resource-constrained world. Its robust design maximizes total cost of ownership, delivering significant savings for hospital systems, emergency stockpiles, long-term acute care hospitals (LTACHs) and skilled nursing facilities (SNFs).”

Company Statement

Richard S. Walsh, President and CEO, stated, “Achieving FDA 510(k) clearance for the RESPOND ventilator is a testament to our commitment to advancing medical technology and addressing the critical needs of patients and healthcare professionals. This accomplishment not only reinforces our dedication to innovation but also marks a significant step in revitalizing U.S. manufacturing in the medical device sector.” The company plans to expand its product line with additional value-based solutions for its customers.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

Related Topics

FDA Grants 510(k) Clearance to RELIEF Stent for Vesicoureteral Reflux

The FDA has approved the RELIEF ureteral stent for preventing vesicoureteral reflux, marking the first such approval in the U.S. The stent, developed by The Ureteral Stent Company, aims to address the significant side effects associated with current stents, such as reflux and bladder spasms, through its unique design.

Lungpacer's AeroPace System Receives FDA Approval for Ventilator Weaning

The FDA has granted premarket approval to Lungpacer Medical's AeroPace System, a neurostimulation therapy designed to improve weaning outcomes for adults on mechanical ventilation.
AeroPace stimulates the phrenic nerves to strengthen the diaphragm, leading to improved breathing and reduced dependence on mechanical ventilation for patients ventilated for at least 96 hours.

InnoCare Urologics wins FDA nod for urinary safety catheter - MassDevice

Paragonix KidneyVault Receives FDA Clearance for Portable Kidney Perfusion

Paragonix Technologies' KidneyVault, a portable hypothermic perfusion system, has received FDA 510(k) clearance to improve donor kidney preservation during transport.
The KidneyVault system integrates digital monitoring with perfusion technology, aiming to expand the donor kidney pool and enhance organ quality for transplantation.

Paragonix Technologies' KidneyVault Receives FDA Clearance for Portable Kidney Perfusion

Paragonix Technologies has received FDA 510(k) clearance for its KidneyVault System, a portable hypothermic perfusion device for donor kidney preservation.
The KidneyVault integrates digital monitoring with perfusion technology, aiming to improve kidney preservation during transport and expand the donor pool.

Vantis Vascular's CrossFAST Guide Extension System Receives FDA Clearance

Vantis Vascular has received FDA 510(k) clearance for its CrossFAST Integrated Microcatheter Guide Extension System, designed for complex coronary and peripheral interventions.
The CrossFAST system utilizes patented DuoPro Interlocking Technology to enhance deliverability and safety in challenging anatomies, potentially improving patient outcomes.

Vantis Vascular's CrossFAST Guide Extension System Receives FDA Clearance for Complex Vascular Interventions

Vantis Vascular's CrossFAST Integrated Microcatheter Guide Extension System has received FDA 510(k) clearance, designed to improve the speed and safety of vascular procedures.
The CrossFAST system utilizes patented DuoPro Interlocking Technology to enhance deliverability in complex, calcified, and tortuous anatomies, addressing limitations of traditional guide extension catheters.

FDA Clears Gentuity's HF-OCT Imaging System for Coronary Interventions

Gentuity receives FDA 510(k) clearance for its HF-OCT imaging system with the Vis-Rx micro-imaging catheter, enhancing coronary intervention procedures.
The system is the only intravascular imaging platform indicated for pre- and post- percutaneous coronary intervention (PCI) assessment, optimizing treatment plans.

FDA Expands Indication for Linear Health Sciences' Orchid SRV to Include Blood Transfusions

The FDA has granted an expanded indication for Linear Health Sciences' Orchid Safety Release Valve (SRV) to include blood and blood product transfusions.
The Orchid SRV is a sterile, single-use connector designed to reduce IV dislodgement and improve the experience for both patients and clinicians.

Restore Medical's ContraBand Device Receives FDA Breakthrough Designation for Heart Failure

Restore Medical's ContraBand system received FDA Breakthrough Device designation for treating heart failure with reduced ejection fraction (HFrEF).
The ContraBand device is a transcatheter pulmonary artery banding (PAB) system designed to improve the quality of life for HFrEF patients.

Reference News

[1]
CorVent wins FDA clearance for Respond critical care ventilator - MassDevice
massdevice.com · Nov 20, 2024

CorVent Medical received FDA 510(k) clearance for its Respond critical care ventilator, designed as a cost-effective, si...

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy